cyclosporine has been researched along with Lysosomal Enzyme Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dickson, P; Jabagat, C; Kakkis, ED; Krieger, A; Le, S; Lester, T; Manuel, H; McEntee, M; Passage, M; Peinovich, M | 1 |
| Ponder, KP | 1 |
| Ferry, GD; Hawkins, EP; Kale, AS | 1 |
3 other study(ies) available for cyclosporine and Lysosomal Enzyme Disorders
| Article | Year |
|---|---|
Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I.
Topics: Animals; Azathioprine; Cyclosporine; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Glycosaminoglycans; Humans; Iduronidase; Immune Tolerance; Immunosuppressive Agents; Kidney; Lysosomal Storage Diseases; Lysosomes; Mitral Valve; Mucopolysaccharidosis I; Recombinant Proteins; Synovial Membrane; Time Factors | 2008 |
Immune response hinders therapy for lysosomal storage diseases.
Topics: Animals; Antibodies; Azathioprine; Cyclosporine; Dogs; Iduronidase; Immune Tolerance; Immunosuppressive Agents; Lysosomal Storage Diseases; Models, Immunological; Mucopolysaccharidosis I; Time Factors | 2008 |
End-stage renal disease in a patient with cholesteryl ester storage disease following successful liver transplantation and cyclosporine immunosuppression.
Topics: Adult; Cholesterol Esters; Cyclosporine; Female; Humans; Hypertension; Immunoglobulin M; Immunosuppression Therapy; Kidney; Kidney Failure, Chronic; Lipase; Liver Transplantation; Lysosomal Storage Diseases | 1995 |